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Introduction
Nuclear factor κB (NF-κB) is a widely expressed primary tran-
scription factor composed of a heterodimeric complex (p65–
p50). A myriad of unrelated exogenous and endogenous stimuli 
are capable of inducing NF-κB activity. In turn, NF-κB regu-
lates the expression of an equally diverse array of cellular genes 
that are important in immunity, infl  ammation, and development 
(Ghosh et al., 1998; Li and Verma, 2002). Aberrance of its func-
tion has been linked to such pathological processes as cancer 
and abnormal development (for review see Rayet and Gelinas, 
1999). Determining molecular mechanisms that regulate the 
activation of NF-κB is crucial to understand how multiple in-
tracellular signaling pathways converge to activate a single 
transcription factor.
NF-κB is normally localized in the cytoplasm as an in-
active complex through physically associating with its inhibi-
tory molecule IκBα. Extensive studies have been performed to 
address how various stimuli trigger its translocation from the 
cytoplasm into the nucleus (Hayden and Ghosh, 2004). Seminal 
works from several laboratories have determined a sequence 
of biochemical events that result in the ubiquitin-dependent 
degradation of IκB proteins (Chen et al., 1996; Hatakeyama 
et al., 1999; Spencer et al., 1999). Consequently, this releases 
NF-κB to move into the nucleus and switch on the expres-
sion of target genes (Ghosh and Karin, 2002; Li and Verma, 
2002). NF-κB belongs to the Rel homology domain (RHD) 
family of transcription factors that exploit similar strategies 
to achieve initial activation. Recently, an alternative pathway 
was identifi  ed to regulate another member (p100) of this family 
(Senftleben et al., 2001).
Compared with the fruitful know-how about the mo-
lecular events of NF-κB activation in cytoplasm, much less 
is understood concerning its active regulation and functional 
interaction with other proteins inside the nucleus. Recent 
progress has shed light on the importance of nuclear events 
in shaping the strength and duration of the NF-κB transcrip-
tional response, which is achieved partly by posttranslational 
modifi  cation of the NF-κB transcription factor complex or the 
histones that surround various NF-κB target genes (Chen and 
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Greene, 2004). For example, I κ-B kinase α (IKKα) was 
demonstrated to accelerate both the turnover of NF-κB and 
its removal from proinfl  ammatory gene promoters (Lawrence 
et al., 2005). This kinase could also phosphorylate histone 
H3 and was critical for NF-κB–responsive gene expression 
(Yamamoto et al., 2003). Additionally, the acetyltransferase 
activity of p300/CREB-binding protein (CBP) was required 
for the activation of NF-κB–dependent transcriptions. p300/
CBP proteins were also found to directly associate with 
NF-κB, forming a bridge to the basal transcriptional machinery 
(Gerritsen et al., 1997; Chan and La Thangue, 2001). Al-
though a couple of cofactors were recently shown to reside 
in the NF-κB enhanceosome, much remains to be done to un-
derstand their specifi  c functions and regulatory mechanisms. 
This indicates that NF-κB assembles a much higher order 
transcription complex than once expected and that there are 
additional important layers of regulation for the NF-κB trans-
activation process.
Ubiquitously expressed transcript (UXT) is  18 kD and 
predominantly localizes in the nucleus (Markus et al., 2002). It 
was demonstrated to be widely expressed in human and mouse 
tissues, and its expression was markedly elevated in some hu-
man tumors (Schroer et al., 1999; Zhao et al., 2005). Computer 
modeling predicted that UXT was an α-class prefoldin (PFD) 
family protein (Gstaiger et al., 2003). Most members of this 
family are small molecular mass proteins (14–23 kD) and are 
composed of coiled-coil structures. Yeast and human PFDs 1–6 
were previously found to assemble into a hexameric complex 
that functioned as a new type of molecular chaperone (Vainberg 
et al., 1998; Siegert et al., 2000).
Until now, the functional characterization of UXT was 
scarce. One recent study indicated that UXT bound to the N termi-
nus of the androgen receptor and regulated androgen receptor–
responsive genes that are important in prostate growth suppression 
and differentiation (Markus et al., 2002; Taneja et al., 2004). 
Another investigation suggested UXT to be a compo  nent of the 
centrosome (Zhao et al., 2005). However, much remains to be 
done as to the in vivo function of UXT and its regulatory roles 
in cellular processes.
During a systematic screening for proteins that inter-
acted with components of the NF-κB enhanceosome, we iden-
tifi  ed UXT as a novel p65-interacting protein. This interaction 
is confi  rmed both in vitro and in vivo. In this study, we show 
that RNAi knockdown of UXT leads to impaired NF-κB activ-
ity and dramatically attenuates the expression of NF-κB–
dependent genes. This interference also sensitizes cells to 
apoptosis by TNF-α. Furthermore, UXT forms a signal-
dependent complex with NF-κB and is recruited to the NF-κB 
enhanceosome upon stimulation. Interestingly, the UXT pro-
tein level correlates with constitutive NF-κB activity in human 
prostate cancer cell lines. The presence of NF-κB within the 
nucleus of stimulated or constitutively active cells is consider-
ably diminished with decreased endogenous UXT protein lev-
els. Collectively, our investigation reveals that UXT is an 
integral component of the NF-κB enhanceosome and is essen-
tial for its nuclear function, which uncovers a new mechanism 
of NF-κB regulation.
Results
Identiﬁ  cation of UXT 
as a p65-interacting protein
To identify new components of the NF-κB enhanceosome, we 
performed a systematic yeast two-hybrid screening in which the 
cDNA fragment harboring the RHD of p65 (amino acids 1–312) 
was used as bait. Several positive clones were identifi  ed to en-
code full-length UXT (Fig. 1 A). In addition, previously con-
fi  rmed p65-interacting proteins (e.g., IκBα and PIAS3) were 
screened out.
UXT was previously reported to be expressed almost ex-
clusively inside the nucleus of most cells (Markus et al., 2002). 
This was confi  rmed in our investigation for either endogenous 
or overexpressed UXT (Fig. 1 B). To further substantiate its in-
teraction with p65, an in vitro coimmunoprecipitation assay was 
applied in which full-length HA-p65 and FLAG-UXT proteins 
were generated and labeled, respectively, with [
35S]methionine 
by in vitro translation. The products were mixed and immuno-
precipitated with either control IgG or anti-HA antibody. As 
shown in Fig. 1 C, UXT could be coprecipitated by antibody 
against the HA epitope but not by control IgG, which suggests 
that UXT indeed interacts directly with full-length p65.
To address the physiological relevance of this interaction 
in mammalian cells, we expressed HA-UXT in 293T cells and 
then stimulated cells with or without TNF-α for the indicated 
times. The fractionated cytoplasmic or nuclear extracts were 
immunoprecipitated with either anti-p65 antibody or IgG as a 
control, respectively. There was no detectable UXT that inter-
acted with cytoplasmic p65 in the presence or absence of TNF-α 
(Fig. 1 D), which was consistent with the unique subcellular 
  location of UXT. In addition, there was only a marginal amount 
of endogenous p65 in the nucleus devoid of TNF-α treatment. 
Consequently, no UXT was coimmunoprecipitated from this 
nuclear extract even though there existed a large amount of 
UXT. In contrast, there exhibited a strong interaction between 
nuclear p65 and UXT upon TNF-α stimulation. Furthermore, 
we tested whether endogenous UXT and p65 could interact in 
response to TNF-α. As shown in Fig. 1 E, endogenous UXT 
was coimmunoprecipitated by p65 antibody from cells treated 
with TNF-α. In contrast, UXT was barely detected in the immuno-
precipitates without TNF-α treatment. One possible explana-
tion for this phenomenon is that only after p65 translocation 
into the nucleus could UXT have access to p65. However, we 
could not formally rule out the possibility that posttranslational 
modifi  cations of either protein were prerequisites for this inter-
action in vivo. Collectively, these results indicate that UXT in-
teracts in vivo with p65 upon TNF-α stimulation.
RHD of p65 mediates its interaction 
with UXT
The p65 subunit of NF-κB harbors an N-terminal conserved re-
gion ( 300 amino acid residues) known as RHD and a C-terminal 
transactivation domain. To explore the UXT-binding region 
within p65, we constructed a series of p65 deletion mutants 
(Fig. 2 A). It was found that the loss of amino acids 1–285 at the 
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with UXT (Fig. 2 B, top). In contrast, p65 fragments spanning 
amino acids 1–286, 1–312, or 1–372 fully retained their binding 
capability and interacted with UXT as well as the wild type 
(Fig. 2 B, middle). Because the RHD of p65 consisted of two 
Ig-like domains (Chen et al., 1998), we made two additional de-
letion mutants of p65 (amino acids 1–190 and 191–551), each 
of which contained only one Ig-like domain. Immunoprecipita-
tion assays revealed that neither of them was able to interact 
with UXT (Fig. 2 B, bottom). In addition, we generated several 
point mutations of UXT and did not observe a considerable 
change on UXT and p65 interaction. We also had attempted in 
vain to express truncation mutants of UXT in mammalian cells, 
which prevented us from further dissecting UXT. Collectively, 
these data suggest that the intact RHD of p65 is both essential 
and suffi  cient to mediate interaction with UXT.
The RHD structure defi  ned a highly conserved family of 
transcription factors (Rel family) that are important in immu-
nity and infl  ammation (Ghosh et al., 1998). This led us to won-
der whether this interaction was also applicable to other proteins 
of this family. To explore this possibility, we transfected UXT 
into 293T cells along with p50 or c-Rel. Interestingly, UXT was 
also capable of binding to p50 or c-Rel specifi  cally and strongly 
(Fig. 2 C). In contrast, lymphoid enhancer binding factor 1, a 
transcription factor unrelated to the Rel family, did not have any 
affi  nity to UXT. This phenomenon suggested that UXT recog-
nized a consensus structure fold and that there was probably a 
unifi  ed theme for its interaction with p65 and other members of 
the Rel family.
Overexpression of UXT does not markedly 
affect NF-𝗋B activation
Because UXT interacted specifi  cally inside the nucleus with 
p65 in a signal-dependent manner, we went on to address 
whether this interaction was important for regulating NF-κB 
activity and genes responsive to it. We transfected 293T cells 
with UXT or other control plasmids, prepared nuclear extracts, 
and performed electrophoretic mobility shift assay (EMSA) as 
indicated. Consistently, there was no NF-κB binding to its cog-
nate probe without TNF-α treatment. Notably, the overexpres-
sion of UXT alone did not induce any detectable basal NF-κB 
binding activity. In contrast, robust NF-κB binding activity was 
induced upon TNF-α stimulation. Expectedly, this activity was 
severely impaired by A20, a potent inhibitor of NF-κB signal-
ing (Wertz et al., 2004). However, in response to TNF-α, we 
observed neither inhibitory nor synergically stimulatory effects 
on NF-κB binding affi  nity (Fig. 3 A).
Alternatively, we explored whether overexpressing UXT 
had any measurable effects on inducible genes such as A20 or 
Figure 1.  UXT interacts with p65 in vitro and 
in vivo. (A) Interaction between p65 and UXT in 
a yeast two-hybrid assay. (B) Subcellular local-
ization of endogenous and exogenous UXT. 
293T cells were transfected with (top) or with-
out (bottom) FLAG-UXT. Immunoﬂ   uorescent-
microscopy was performed with the indicated 
primary antibodies. (C) Full-length HA-p65 
and FLAG-UXT proteins were labeled with 
[
35S]methionine by in vitro translation. The 
products were mixed and immunoprecipitated 
with the indicated antibodies coupled onto pro-
tein A/G beads. The immunoprecipitates were 
resolved by SDS-PAGE and visualized by auto-
radiography. 10% of the input proteins for pull 
down are shown at the left. (D) 293T cells were 
transfected with HA-UXT. 24 h after transfec-
tion, cells were treated with 10 ng/ml TNF-α 
for the indicated times and fractionated to cyto-
plasmic and nuclear fractions, which were 
immunoprecipitated and immunoblotted with 
the indicated antibodies, respectively. (E) 293T 
cells were treated with 10 ng/ml TNF-α for 
the indicated times. Whole cell lysates were 
immunoprecipitated and immunoblotted with 
the indicated antibodies. Bar, 10 μm.JCB • VOLUME 178 • NUMBER 2 • 2007  234
interleukin-8 (IL-8) that were regulated by NF-κB. On transfec-
tion of UXT alone, we did not observe any change on the basal 
expression of these two genes (unpublished data). Thus, we 
transfected 293T cells with UXT or IκBα super repressor (SR) 
and analyzed the amount of A20 or IL-8 mRNA induced by 
TNF-α, respectively, via quantitative real-time RT-PCR. IκBαSR 
was a well-established potent inhibitor of NF-κB activation 
(Diao et al., 2005). Consistently, A20 or IL-8 inductions by 
TNF-α were severely attenuated in the presence of IκBαSR. In-
terestingly, we observed marginal synergic inductions of both 
A20 and IL-8 by TNF-α in the presence of UXT (Fig. 3 B), 
which suggested that UXT might modulate NF-κB function.
Knockdown of UXT sharply attenuates 
NF-𝗋B activation by multiple stimuli
Because we failed via overexpressing UXT to convincingly 
demonstrate the involvement of UXT in NF-κB regulation, we 
turned to investigate the effect if endogenous UXT expression 
was reduced via RNAi. Two UXT siRNAs were fi  shed out, 
which are designated as 242 and 428 hereafter. We confi  rmed 
the effectiveness of them against UXT by monitoring the mRNA 
level (Fig. 4 A), protein level (Fig. 4 B), and cellular immuno-
fl  uorescence of UXT (Fig. 4 C). 428 was reproducibly better 
than 242 and was used more frequently in later experiments. In 
addition, two negative control siRNAs were used. One was a 
nonspecifi  c siRNA and was named as control; the other is a mu-
tant form of siRNA 428 (428m) that could partially bind to 
UXT mRNA but lost the interfering ability.
Initially, we used a κB-Luc reporter gene to evaluate the 
effect of UXT knockdown on NF-κB activation status. Excit-
edly, luciferase assay revealed that the decrease of endogenous 
UXT considerably inhibited NF-κB transcriptional activity 
induced by TNF-α, IL-1β (Fig. 4 D), or lipopolysaccharide 
(Fig. 4 H). Notably, this phenomenon also held true for basal 
luciferase expression. Likewise, similar effects were observed 
in cells with reduced UXT expression when the cells were stimu-
lated by overexpressing MyD88 or TRAF6, which are well 
known to induce NF-κB activity (Fig. 4 E; Muzio et al., 1997; 
Figure 2.  RHD of NF-𝗋B mediates its interaction with UXT. (A) Schematic illustration of p65 and its mutants. RHD, Rel homology domain; NLS, nuclear 
localization signal; TAD, transactivation domain. (B) Tagged full-length UXT was transfected into 293T cells along with p65 and its deletion mutants as 
indicated. Whole cell lysates were immunoprecipitated and immunoblotted with the indicated antibodies. (C) 293T cells were transfected with FLAG-UXT 
together with HA-p50, myc-cRel, and HA–lymphoid enhancer binding factor 1. Cell lysates were immunoprecipitated and immunoblotted with the indi-
cated antibodies.UXT AS AN ESSENTIAL COFACTOR FOR NF-𝗋B • SUN ET AL. 235
Deng et al., 2000). In addition, gene activation induced by p65 
alone was also markedly attenuated in cells with a decreased 
expression of endogenous UXT (Fig. 4 F).
Our data have shown that UXT could interact with other 
Rel family proteins like c-Rel (Fig. 2 C). c-Rel was previously 
found to regulate the expression of the IL-12 p40 subunit by 
specifi  cally interacting with its promoter (Gri et al., 1998). Thus, 
a reporter gene was used that harbored fi  refl  y luciferase under 
the control of the mouse p40 promoter. Consistently, c-Rel 
activation was severely impaired in cells expressing reduced 
amounts of UXT. This attenuation was in direct proportion 
to the intensity of RNAi, as evidenced in oligonucleotides 428 
versus 242 (Fig. 4 G).
To make it more physiologically relevant, we also investi-
gated how the induction of NF-κB–dependent genes (IL-8, A20, 
and IκBα) was infl  uenced by knocking down endogenous UXT 
expression. For cells transfected with control siRNA or UXT 
siRNA, quantitative real-time RT-PCR was used to measure en-
dogenous mRNA levels of IL-8, A20, and IκBα induced by 
TNF-α during a time course. Consistently, these inductions 
were sharply attenuated when endogenous UXT expression was 
suppressed (Fig. 4 I). Collectively, our data strongly indicate 
that UXT is required for inducing genes tightly regulated by 
NF-κB and that it plays an essential role in NF-κB function.
Knockdown of UXT attenuates NF-𝗋B 
binding to its cognate promoter
As was stated in the Introduction, NF-κB activation involved a 
series of molecular events both in the cytoplasm and in the nucleus. 
To rule out the possibility that UXT might act on processes 
other than directly on NF-κB itself, we examined the effects of 
UXT knockdown on the phosphorylation and degradation of 
IκBα. We did not fi  nd any differences in this regard between 
UXT-defi  cient and normal cells during TNF-α stimulation (Fig. 
5 A). This was further supported by the observation that IKK 
kinase activity was not affected at all in terms of UXT knock-
down (unpublished data). Given that UXT was expressed almost 
exclusively inside the nucleus and interacted directly with 
NF-κB, these data strongly indicate that UXT performed its 
function via targeting NF-κB itself.
Via EMSA, we then analyzed endogenous NF-κB DNA 
binding activity in cells with reduced UXT expression. Expect-
edly, TNF-α alone induced endogenous NF-κB to bind to its cog-
nate probe strongly and specifi  cally. Considerably, this interaction 
was markedly diminished in nuclear extracts from UXT-specifi  c 
knockdown cells. In addition, this reduction was correlated with 
the effectiveness of the siRNA administered (Fig. 5 B).
To substantiate this fi  nding, we took advantage of the chro-
matin immunoprecipitation (ChIP) assay to examine whether 
binding of NF-κB to its endogenous promoter was infl  uenced in 
vivo when the expression of UXT was diminished. Consistently, 
defi  ciency of the endogenous UXT level resulted in consider-
able decreases in the amount of p65 associated with its endoge-
nous cognate promoters upon TNF-α stimulation. In addition, 
this was also true for other components of the NF-κB transcrip-
tional enhanceosome such as p50 and RNA polymerase II. Un-
derstandably, defi  ciency of the endogenous UXT level had no 
effect on the glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) transcriptional complex (Fig. 5 C). Collectively, 
these fi  nding indicate that UXT plays an important role in the 
NF-κB enhanceosome.
UXT maintains the presence of NF-𝗋B 
inside the nucleus
A previous study has predicted UXT as an α-class PFD family 
protein via computer modeling (Gstaiger et al., 2003). Some 
members of this family were previously found to assemble into 
a hexameric complex that functioned as a molecular chaperone 
in protein folding and stability (Vainberg et al., 1998). Thus, we 
hypothesized that UXT performed its function by serving as a 
specifi  c molecular chaperone for NF-κB inside the nucleus.
To explore this hypothesis, we investigated whether the 
nuclear presence of p65 was infl  uenced by UXT. Therefore, 
293T cells were transfected with or without the indicated siRNAs 
and stimulated with or without TNF-α as shown. Interestingly, 
the amount of nuclear p65 was markedly diminished in cells 
that were treated with siRNA against UXT even though these 
cells were stimulated with TNF-α. Notably, siRNA 428 was 
better than siRNA 242 in causing the loss of nuclear p65. In 
contrast, control siRNA displayed no such effect on the nuclear 
presence of p65. The transcription factor sp1 as a negative con-
trol was expressed constitutively inside the nucleus and re-
mained intact in response to UXT knockdown. The cytoplasmic 
reservoir of p65 did not seem to be affected by siRNA against 
UXT (Fig. 5 D). This suggested that UXT positively regulated 
p65 inside the nucleus, and the loss of it affected the sustained 
Figure 3.  Overexpression of UXT does not markedly affect NF-𝗋B acti-
vation induced by TNF-𝗂. (A) 293T cells were transfected with an equal 
amount of UXT, A20, or control vector. 24 h after transfection, cells were 
stimulated with 10 ng/ml TNF-α for the indicated times. Equal amounts 
(10 μg) of nuclear extracts were subjected to EMSA. For competition 
analysis, 100-fold excess of unlabeled wild-type or mutant κB probes 
were added to the reaction mixtures. For supershift assays, nuclear ex-
tracts were incubated with antibody as indicated. (B) 293T cells were 
transfected with equal amounts of UXT, ΙκBαSR, or empty vector. 24 h 
after transfection, cells were stimulated with 10 ng/ml TNF-α for 30 min 
or left untreated. Relative mRNA levels of A20 and IL-8 were analyzed by 
real-time RT-PCR. Data represent means ± SD (error bars) of at least three 
independent experiments.JCB • VOLUME 178 • NUMBER 2 • 2007  236
action of p65 in the nucleus, which led to the attenuated EMSA 
results as observed in Fig. 5 B. Alternatively, we performed 
immunofl  uorescence analysis to support this speculation. Interest-
ingly, when transfecting cells with siRNA against UXT and 
stimulating them with TNF-α, there were an apparently de-
creased percentage of cells that displayed focused nuclear p65. 
Approximately 90% of control cells displayed p65 inside the 
nucleus upon stimulation, whereas only 35–50% displayed p65 
in the case of the UXT knockdown specimen (Fig. 5 E). Collec-
tively, these data indicate that UXT is a stabilizing factor for the 
NF-κB transcriptional enhanceosome.
One possible mechanism for the aforementioned phenom-
enon is that the loss of UXT releases NF-κB from the enhanceo-
some, which consequently causes NF-κB to be exported out 
into the cytoplasm. To address this hypothesis, leptomycin B 
(LMB), a specifi  c inhibitor of nuclear export (Ullman et al., 1997; 
Figure 4.  Knockdown of UXT attenuates NF-𝗋B activation induced by speciﬁ  c stimuli. (A) 293T cells were transfected with the indicated siRNA. 48 h after 
transfection, the endogenous expression of UXT mRNA was monitored by RT-PCR (top) or by real-time RT-PCR (bottom). (B) Cell lysates from A were sub-
jected to Western blotting for determining endogenous UXT protein levels after siRNA transfection. (C) FLAG-UXT was cotransfected with the indicated 
siRNA. 24 h after transfection, UXT protein levels were monitored by immunoﬂ  uorescence. (D) 293T cells were cotransfected with 3×κB-Luc and siRNA as 
indicated. 48 h after transfection, cells were stimulated with 10 ng/ml TNF-α or 20 ng/ml IL-1 for 7 h before luciferase assays were performed. (E) The indi-
cated siRNA and 3×κB-Luc were transfected into 293T cells along with MyD88 or TRAF6. 48 h after transfection, cells were assayed as in D. (F) p65 was 
transfected into 293T cells along with the indicated siRNA and 3×κB-Luc. Cells were treated and assayed as in E. (G) c-Rel was transfected into 293T cells 
along with the indicated siRNA and mp40-Luc. Cells were treated and assayed as in E. (H) RAW264.7 cells were cotransfected with 3×κB-Luc and the in-
dicated siRNA. 48 h after transfection, cells were stimulated with 500 ng/ml lipopolysaccharide for 7 h before luciferase assays were performed. (I) 293T 
cells were transfected with the indicated siRNA and stimulated by 10 ng/ml TNF-α for the indicated times. Endogenous mRNA expressions of IL-8, A20, 
and IκBα were measured by real-time RT-PCR. Data represent means ± SD (error bars) of at least three independent experiments. Bar, 200 μm.UXT AS AN ESSENTIAL COFACTOR FOR NF-𝗋B • SUN ET AL. 237
Figure 5.  Knockdown of UXT attenuates the activity and amount of nuclear NF-𝗋B. (A) 293T cells were transfected with the indicated siRNAs. After 48 h, 
cells were induced by 10 ng/ml TNF-α for the indicated times. Western blotting was performed on the cell extracts to check the phosphorylation and deg-
radation of IκBα. (B) 293T cells were treated as in A. EMSA was performed to test endogenous NF-κB or sp1 binding to their cognate probes. (C) 293T 
cells were treated as in A. The ChIP assays were performed in terms of A20, IκBα, or GAPDH promoters using antibodies and corresponding primers as 
described. (D) 293T cells were transfected with the indicated siRNAs. After 48 h, cells were induced by 10 ng/ml TNF-α for 30 min. Cytoplasmic and nu-
clear fractions were prepared and immunoblotted with the indicated antibodies, respectively. (E) Cells were treated as in D and stained with anti-p65 pri-
mary antibody and FITC-conjugated secondary antibody. The nucleus was counterstained with DAPI. Quantiﬁ  cation was performed to 100–200 cells in 
the same ranges of microscopy ﬁ  eld for the presence of an appreciable nuclear signal of p65. Only those showing typical focused nuclear p65 were 
counted. The data are presented as percentages of cells with nuclear p65 versus total cells. (F) 293T cells were transfected with siRNA 428. After 48 h, 
cells were induced by 10 ng/ml TNF-α or 10 ng/ml TNF-α plus 20 ng/ml LMB for the indicated times and stained with anti-p65 primary antibody and 
FITC-conjugated secondary antibody. The nucleus was counterstained with DAPI. (G) 293T cells were cotransfected with the indicated siRNAs, 3×κB-Luc, 
and chimeric p65 (1–312)-VP16. Luciferase assays were performed 48 h after transfection. (H) 293T cells were cotransfected with the indicated siRNAs, 
Gal4-Luc, and chimeric Gal4 BD-p65 (285–551). Luciferase assays were performed 48 h after transfection. Data represent means ± SD (error bars) of at 
least three independent experiments. Bars, 20 μm.JCB • VOLUME 178 • NUMBER 2 • 2007  238
Ghosh and Karin, 2002), was used. Cells were transfected 
with siRNA against UXT and stimulated with TNF-α in the 
presence or absence of LMB. Immunofl  uorescence analysis in-
dicated that LMB considerably increased the nuclear accumula-
tion of p65 even though the endogenous UXT was knocked 
down, which suggests that UXT contributed to the sustained 
presence of p65 inside the nucleus. We have also tested other 
possibilities, but no obvious correlation could be drawn at pres-
ent (see Discussion).
Our data formerly indicated that RHD of p65 was es-
sential and suffi  cient to mediate the interaction between p65 
and UXT (Fig. 2 B). We wondered whether this stabilizing 
effect of UXT was applicable to any proteins containing this 
domain. To address this speculation, we constructed two fus-
ing proteins, p65 (1–312)-VP16 and Gal4 BD-p65 (285–551): 
the former one harbors the RHD, whereas the latter one spans 
all of p65 except RHD. Luciferase assays were performed to 
monitor the effect of UXT knockdown on activations of indi-
cated reporters induced by these chimeric proteins. Interest-
ingly, the knockdown of UXT inhibited the activity induced 
by p65 (1–312)-VP16 (Fig. 5 G) but not that induced by Gal4 
BD-p65 (285–551) (Fig. 5 H). Collectively, these data indi-
cate that UXT directly modulates the nuclear function 
of NF-κB.
The siRNA-resistant form of UXT 
rescues the phenotype of its 
endogenous knockdown
To rule out possible off-target effects of the siRNA against UXT, 
a siRNA-resistant UXT (UXTr) was generated in which silent 
mutations were introduced into the sequence targeted by siRNA 
428 and without changing the amino acid sequence of the pro-
teins expressed. The usefulness of UXTr was confi  rmed so 
that siRNA 428 no longer had any effects on UXTr but siRNA 
242 could still interfere with UXTr expression (Fig. 6 A). The 
exogenous wild-type UXT or UXTr was transfected together 
with siRNA 428 and stimulated with TNF-α as indicated, re-
spectively. Nuclear and cytoplasmic extracts were probed with 
indicated antibodies. As shown in Fig. 6 B, the expression of 
UXTr rescued the loss of nuclear p65 caused by endogenous 
UXT impairment, whereas the expression of wild-type UXT 
failed to do so. This rescuing effect was also confi  rmed with 
EMSA assays (Fig. 6 C). Collectively, these data indicate that 
the loss of nuclear p65 was directly caused by impairment of 
UXT function and that there was a direct functional connection 
between p65 and UXT.
UXT is dynamically recruited to the NF-𝗋B 
enhanceosome upon stimulation in vivo
Given that UXT interacted with p65 and was essential to main-
tain the presence of NF-κB inside the nucleus, we wondered 
whether UXT was an integral component of the NF-κB tran-
scriptional enhanceosome in vivo. To address this possibility, 
we transfected HA-UXT into 293T cells and performed system-
atic ChIP assays on the promoters of A20 and IκBα as described 
in Materials and methods. It turned out that UXT was indeed 
present within the NF-κB transcriptional enhanceosome. Nota-
bly, its presence became much more prominent upon stimula-
tion, which suggested that UXT was dynamically recruited onto 
the enhanceosome. In addition, UXT had nothing to do with the 
transcription complex on the GAPDH promoter, indicating the 
selectivity of UXT action (Fig. 7 A). We also stimulated 293T 
cells and performed similar ChIP assays to confi  rm again that 
endogenous UXT was recruited onto the NF-κB enhanceosome 
in response to stimulation (Fig. 7 B).
Alternatively, we performed supershift assay to further 
substantiate this observation. Stimulation of 293T cells with 
TNF-α led to a strong NF-κB DNA-binding band composed of 
κB probe, NF-κB, and its cofactors in EMSA. Interestingly, this 
EMSA band was markedly diminished when antibody against 
UXT was introduced into the reaction mixture (Fig. 7 C), which 
strongly suggests that UXT is an integral component in this 
band and that it is of importance to foster an NF-κB conforma-
tion amenable to its binding. Collectively, these data indicate 
that UXT forms a dynamic complex with p65 in vivo and is re-
cruited to the NF-κB enhanceosome after stimulation.
The NF-κB enhanceosome consisted of a growing list of 
transcriptional cofactors. Our current fi  nding that UXT was one 
of them and that it was able to maintain the stability of the NF-κB 
enhanceosome led us to ask whether other factors could also ac-
complish this function. Coactivator-associated arginine methyl-
transferase 1 (CARM1) is known to be a transcriptional cofactor 
Figure 6.  Rescue of the UXT knockdown effects with a 
siRNA-resistant form. (A) The HA-tagged wild-type UXT 
and siRNA-resistant UXT (UXTr) were cotransfected 
with the indicated siRNAs. After 24 h, cell lysates were 
subjected to Western blotting for determining exog-
enous UXT protein levels. (B) 293T cells were trans-
fected with the indicated exogenous UXT and siRNAs. 
After 48 h, cells were induced by 10 ng/ml TNF-α for 
the indicated times. Cytoplasmic and nuclear fractions 
were prepared and immunoblotted with the indicated 
antibodies, respectively. (C) 293T cells were treated as 
in B. EMSA was performed to test endogenous NF-κB 
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in the NF-κB enhanceosome. Cells with a reduced expression of 
CARM1 showed an impaired expression of NF-κB–dependent 
genes upon stimulation (Covic et al., 2005; Teferedegne et al., 
2006). However, immunofl  uorescence and EMSA experiments 
indicated that the knockdown of CARM1 did not affect the 
nuclear presence of p65 (Fig. 7, E and F), which suggested that 
UXT played a unique role toward NF-κB function.
Knockdown of UXT sensitizes 293T cells 
to apoptosis induced by TNF-𝗂
It was well established that NF-κB promotes the survival of 
most cells through the transcriptional induction of antiapoptotic 
genes (Barkett and Gilmore, 1999; Zong et al., 1999). Normally, 
293T cells would not display apoptotic phenomenon in the 
presence of TNF-α (<3%). However, loss of NF-κB function 
would make cells prone to apoptosis. This was confi  rmed by 
knocking down UXT upon TNF-α stimulation ( 15%; unpub-
lished data). Cycloheximide (CHX) is a potent protein synthesis 
inhibitor. However, at the concentration of ≤10 μg/ml, CHX 
only reduces but does not completely block de novo protein 
synthesis (Tang et al., 2001). Interestingly, a low concentration 
of CHX could dramatically augment the apoptotic effects (Yeh 
et al., 1997; Kelliher et al., 1998). Taking advantage of this cell 
model, we explored whether UXT was important for cell sur-
vival in response to TNF-α treatment. As was shown in Fig. 8, 
TNF plus 5 μg/ml CHX resulted in  10% cell death after 18 h 
of treatment. More importantly, when siRNA of UXT, which 
blocked NF-κB activity, was used in combination with TNF 
and CHX, we detected drastically morphological changes under 
light microscopy and  50% of cells undergoing apoptosis. Al-
ternatively, we used annexin V and TUNEL methods to quanti-
tatively measure the percentages of cells undergoing apoptosis. 
Consistently, a considerable increase of apoptotic cells was ob-
served in samples with reduced UXT (Fig. 8, B and C). These 
indicated that the knockdown of UXT sensitizes 293T cells to 
apoptosis induced by TNF-α.
Endogenous UXT expression correlates 
with NF-𝗋B activation in human prostate 
cancer cell lines
Prostate cancer began as an androgen-dependent tumor and 
progressed into an androgen-independent tumor. In this prog-
ress, NF-κB activity started to behave out of control (Chen and 
Sawyers, 2002; Zerbini et al., 2003). In androgen-independent 
PC-3 cells, more NF-κB localized inside the nucleus and con-
stitutively displayed DNA binding activity, whereas it exhibited 
barely detectable activity in androgen-sensitive LNCaP cells 
(Palayoor et al., 1999). We confi  rmed these observations as 
shown in Fig. 9 B, which indicate that these two cells are ideal 
models for studying NF-κB regulation within the nucleus.
Figure 7.  UXT forms a dynamic complex with 
NF-𝗋B and is recruited to the NF-𝗋B enhanceo-
some upon stimulation. (A and B) 293T cells 
transfected with (A) or without (B) UXT. After 
10 ng/ml TNF-α stimulation, ChIP assays were 
performed on A20, IκBα, or GAPDH promot-
ers as described. (C) 293T cells were induced 
by 10 ng/ml TNF-α for 30 min, and nuclear 
extracts were prepared and incubated with the 
indicated antibodies to perform EMSA super-
shift assays. (D) 293T cells were transfected 
with CARM1 siRNA. 48 h after transfection, 
the endogenous CARM1 mRNA was shown by 
RT-PCR. (E) 293T cells were transfected with 
CARM1 or UXT siRNA and treated with 10 
ng/ml TNF-α for 30 min or were left untreated. 
Cover slides were subjected to immunoﬂ  uores-
ence assay with anti-p65 antibody. (F) 293T 
cells were transfected and treated as in E. Nu-
clear lysates were used for EMSA to check en-
dogenous NF-κB or sp1 DNA binding activities. 
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In addition, a former study indicated that the UXT mRNA 
level was considerably elevated in PC-3 as compared with 
LNCaP cells (Markus et al., 2002). We confi  rmed this observation 
in terms of UXT mRNA (not depicted) and also found that this 
was true for the protein level of endogenous UXT (Fig. 9 A). 
Given that UXT was recruited onto the NF-κB enhanceosome 
upon stimulation and that it is essential to maintain the presence 
of NF-κB inside the nucleus, these results suggest a possible 
correlation between UXT levels and NF-κB activation.
To further explore this possibility, we determined whether 
the inhibition of endogenous UXT expression would affect the 
constitutive amount of nuclear NF-κB in PC-3 cells. As shown 
in Fig. 9 C, this interference indeed reduced the amount of nu-
clear NF-κB in this cell, which is consistent with that observed 
in 293T cells stimulated by TNF-α. In addition, luciferase assay 
revealed that the decrease of UXT expression suppressed the 
constitutive transcriptional activity of NF-κB in PC-3 cells (Fig. 
9 D). Furthermore, EMSA confi  rmed that the loss of UXT also 
Figure 8.  Knockdown of UXT sensitizes 293T cells to TNF-𝗂–induced apoptosis. (A) 293T cells were transfected with the indicated siRNAs. 48 h after 
transfection, cells were treated with 50 ng/ml TNF-α plus 5 μg/ml CHX or were left untreated for 18 h. Representative microscopic images are shown. 
(B and C) Cells were prepared as in A. After that, cells were analyzed using the annexin V (B) or TUNEL assay (C) to monitor cell apoptosis. The percent-
ages indicate the fractions of positive annexin V cells in total cells. Data represent means ± SD (error bars) of at least three independent experiments. 
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suppressed the constitutive DNA binding activity of NF-κB but 
not the control sp1 (Fig. 9 E). These results indicate that the 
elevated expression of UXT strongly correlates with constitu-
tive NF-κB activity in prostate cancer cell lines and again sub-
stantiates the notion that UXT is essential for NF-κB function 
in the nucleus.
Discussion
The NF-κB family of transcription factors is crucial for many 
key cellular processes. Recently, the regulation of NF-κB activ-
ity has been cast in the limelight (Dixit and Mak, 2002; Ghosh 
and Karin, 2002). A handful of transcriptional cofactors were 
implicated in this process. For example, p300/CBP played a 
major role in the acetylation of p65 in vivo (Chen et al., 2002). 
Conversely, acetylated p65 was subjected to deacetylation by 
HDAC3 (Chen et al., 2001). Recent work also revealed that 
SIRT1 physically interacted with p65 and promoted p65 deacet-
ylation (Yeung et al., 2004). In addition, NF-κB was reported to 
be phosphorylated at multiple sites during activation. For exam-
ple, IKKα was demonstrated to accelerate both the turnover of 
NF-κB and its removal from proinfl  ammatory gene promoters 
(Lawrence et al., 2005). An emerging theme is that there are ad-
ditional important layers of regulation for nuclear NF-κB.
Regulating the duration of the nuclear presence of p65 is 
another potential mechanism to modulate the NF-κB transcrip-
tional response. In this study, we characterized UXT as a novel 
and essential cofactor for NF-κB function in its enhanceosome. 
Several lines of fi  ndings support this argument. (1) UXT was 
shown to interact directly with p65 both in vitro and in vivo. 
Importantly, this interaction was dependent on external stimuli. 
Because UXT was almost exclusively present inside the nu-
cleus, we reasoned that only after NF-κB translocation into 
the nucleus could this interaction take place, which was also sub-
stantiated by the observation that NF-κB was constitutively in-
side the nucleus in PC-3 cells and regulated by UXT as a result. 
(2) ChIP and EMSA assays demonstrated that UXT localized 
inside the NF-κB enhanceosome in vivo and was recruited to it 
upon stimulation. (3) The knockdown of UXT did not infl  uence 
the molecular events of NF-κB activation outside the nucleus. 
Instead, it decreased the amount of nuclear p65 and severely 
impaired NF-κB activation. This decrease could be rescued by 
a siRNA-resistant exogenous UXT. (4) Overexpression of UXT 
caused marginal synergic inductions of both A20 and IL-8 in 
response to TNF-α. We reasoned that there was a sufficient 
amount of endogenous UXT within the nucleus in 293T cells so 
that it would be diffi  cult to demonstrate the synergic effect more 
dramatically. Convincingly, RNAi of UXT resulted in apparent 
attenuations of NF-κB–responsive reporter expression by vari-
ous stimuli and, ultimately, the inducible expression of genes 
tightly regulated by NF-κB. (5) The reduction of endogenous 
UXT tamed cells prone to apoptosis that was induced by TNF-α, 
which is a known index for the impairment of NF-κB function. 
(6) PC-3 cells displayed constitutive NF-κB activity inside the 
nucleus. This was nicely correlated with the elevated presence 
of both NF-κB and UXT within the nucleus, which was also 
consistently substantiated by the loss of NF-κB and its activity 
when endogenous UXT was diminished in PC-3 cells. Thus, UXT 
might function to extend the duration of NF-κB or its enhanceo-
some inside the nucleus.
Figure 9.  UXT protein level correlates with 
the constitutive NF-𝗋B activity in human pros-
tate cancer cell lines. (A) Equal amounts of 
whole cell lysates from LNcaP or PC-3 prostate 
cancer cells were immunoblotted with the indi-
cated antibodies. (B) 10 μg of nuclear extracts 
from LNCaP or PC-3 were subjected to EMSA 
with a radiolabeled κB or sp1 probe. NS, non-
speciﬁ  c band. (C) PC-3 cells were transfected 
with the indicated siRNAs. 48 h after transfec-
tion, cytoplasmic and nuclear fractions were 
prepared and immunoblotted with the indi-
cated antibodies, respectively. (D) PC-3 cells 
were cotransfected with the indicated siRNAs 
and 3×κB-Luc. Luciferase assays were per-
formed 48 h after transfection. Data represent 
means ± SD (error) of at least three indepen-
dent experiments. (E) PC-3 cells were trans-
fected with the indicated siRNAs. 48 h after 
transfection, nuclear extracts were prepared. 
Endogenous NF-κB or sp1 DNA binding activ-
ities were examined by EMSA.JCB • VOLUME 178 • NUMBER 2 • 2007  242
This function was probably achieved by fostering a favor-
able conformation for NF-κB in its enhanceosome. UXT was 
recently predicted as a new member of the α-class PFD family 
protein. Yeast and human PFDs 1–6 assembled into a hexameric 
complex, which functioned as a molecular chaperone in protein 
folding. Our preliminary data also suggested that UXT forms 
oligomers in vivo (unpublished data). Some members of the 
PFD family protein were implicated to participate in transcrip-
tional regulation, such as PFDN5 (MM1) in c-myc transcription 
(Satou et al., 2001) and URI in the rapamycin-sensitive tran-
scription response (Gstaiger et al., 2003). However, the specifi  c 
mechanisms of their action remain unknown. We have gener-
ated several point mutations of UXT (C75A, L32P, L50P, L59P, 
and L32P/L50P/L59P) and did not reveal any substantial corre-
lation between UXT and p65 interaction. Our speculation is that 
a three-dimensional juxtaposed motif may be involved in this 
interaction. Structural analysis of UXT and NF-κB interaction 
is under way in our laboratory, and hopefully this will shed light 
on how UXT performs this regulatory role.
Recently, studies suggested that the ubiquitin–proteasomal 
degradation pathway was also involved in stringent control of 
the promoter-bound p65 (Ryo et al., 2003; Saccani et al., 2004). 
An NF-κB coactivator, Pin1, was found to bind p65 and prevent 
SOCS-1–mediated ubiquitination (Ryo et al., 2003). We have 
tried to address whether the ubiquitin–proteasome pathway is 
critical for p65 stability in the context of UXT, but no conclu-
sion can be made as of now. The problem lies in the fact that 
most proteins are instantly degraded after ubiquitination, which 
is also the case for p65. To prevent this obstacle, proteasome 
inhibitors were used to stabilize ubiquitinated proteins. Unfor-
tunately, a critical step during NF-κB activation involved protea-
some function (i.e., IκBα degradation), which makes it unpractical 
to probe endogenous p65 degradation inside the nucleus. The 
few papers that reported nuclear p65 ubiquitination often used 
the overexpression of p65 to answer this question, which was a 
controversial approach. After this method, we did observe 
traces of p65 ubiquitination when UXT was knocked down (un-
published data), which was comparable with published reports 
(Ryo et al., 2003). However, we believe it is too early to corre-
late the loss of UXT with p65 ubiquitination. Substantially, we 
found that LMB, a specifi  c inhibitor of nuclear export, increased 
the nuclear accumulation of p65 even though the endogenous 
UXT was knocked down. More likely, UXT infl  uenced p65 
nucleocytoplasmic shuttling.
Given the fi  ndings from this study, we favor the notion 
that UXT is a nuclear chaperone that promotes formation of 
the NF-κB enhanceosome. Nuclear chaperones usually medi-
ate nucleosome assembly and remodeling (Philpott et al., 
2000; Loyola and Almouzni, 2004). Furthermore, they were 
implicated to directly regulate transcription factors. For exam-
ple, a nuclear chaperone termed FACT (facilitates chromatin 
transcription) could facilitate transcript elongation through nu-
cleosomes (Orphanides et al., 1998). Another human nuclear 
chaperone (bZIP-enhancing factor) promoted the transcriptional 
activity of bZIP (basic region–leucine zipper DNA-binding do-
main) proteins (Virbasius et al., 1999). JDP2 was recently dem-
onstrated to be a chaperone for AP1 (Jin et al., 2006). In addition, 
nuclear chaperones can also negatively regulate transcription. 
For example, nuclear chaperones p23 and Hsp90 bound to 
glucocorticoid-induced regulatory complexes and consequently 
disassembled these complexes (Freeman and Yamamoto, 2002). 
In conclusion, nuclear chaperones have regulatory functions 
targeted to their specifi  c client proteins other than the classic 
functions involved in protein synthesis and maturation. More 
work needs to be done before the function and mechanism of 
UXT action are fully understood.
Numerous reports have documented considerable correla-
tions between NF-κB activation and specifi  c types of cancer (for 
review see Rayet and Gelinas, 1999). By promoting proliferation 
and inhibiting apoptosis, NF-κB could tip the balance between 
proliferation and apoptosis toward malignant behavior in tumor 
cells (for review see Rayet and Gelinas, 1999). Prostate cancer 
begins as an androgen-dependent tumor and progresses into an 
androgen-independent tumor. In this progress, NF-κB activity is 
up-regulated (Chen and Sawyers, 2002; Zerbini et al., 2003). In 
this study, we provide a new thread of explanation for this corre-
lation and demonstrate that UXT is essential for the constitutive 
activity of NF-κB in prostate cancer cells.
Collectively, our study reveals that UXT is an integral 
component of the NF-κB enhanceosome and is essential for its 
function in the nucleus. UXT may function as a specifi  c molec-
ular chaperone for NF-κB in this process. Future investigations 
will focus on how UXT interacts with NF-κB and regulates the 
dynamic processes of NF-κB within the nucleus.
Materials and methods
Reagents
Monoclonal UXT antibodies 6D3 and 105.128 were provided by M.I. 
Greene (University of Pennsylvania, Philadelphia, PA) and W. Krek 
(Eidgenössische Technische Hochschule Honggerberg, Zurich, Switzerland), 
respectively. UXT siRNA duplexes were chemically synthesized by Gene-
Pharma. The UXT siRNA sequences were as follows: 242, A  G  C  A  C  U  C-
G  G  A  G  U  U  A  U  A  U  A  U  dTdT; 428, C  C  A  A  G  G  A  C  U  C  C  A  U  G  A  A  U  A  U  dTdT; and 
428M1, C  C  A  A  C  C  C  C  U  C  C  A  U  G  A  A  U  A  U  dTdT. The control siRNA sequence 
was U  U  C  U  C  C  G  A  A  C  G  U  G  U  C  A  C  G  U  dTdT, and the CARM1 siRNA sequence 
was G  C  A  G  U  C  C  U  U  C  A  U  C  A  U  C  A  C  C  dTdT. Other commercially available 
reagents and antibodies used were as follows: HA, p65, p65, p50, IκBα, 
and RNA polymerase II antibodies were purchased from Santa Cruz Bio-
technology, Inc. Flag, sp1, and β-actin antibodies were obtained from 
Sigma-Aldrich. Anti-myc was purchased from Wolwobiotech. rhTNFα and 
RhIL-1β was purchased from R&D Systems, and lipopolysaccharide was 
obtained from Sigma-Aldrich.
Plasmids
UXT and its deletion mutants were constructed by PCR from the human thy-
mus library and subsequently cloned into mammalian expression vectors 
as indicated. The UXT siRNA-resistant form was generated by introducing 
four silent mutations (373 A  C  A  A  A  A  G  A  T  A  G  C   384) in the siRNA 428 tar-
get sequence. Flag-IκBαSR, Flag-TRAF6, and the reporter genes (3×κB-luc 
and pRL-SV40) have been described previously (Diao et al., 2005). 
pcDNA3-HA-p65 was a gift from G. Pei (Shanghai Institute of Biochemistry 
and Cell Biology [SIBCB], Shanghai, China), and its deletion mutants were 
constructed by PCR. MyD88 was ampliﬁ  ed from the human thymus library 
and subcloned into pcDNA3.1-Flag vector. HA–lymphoid enhancer bind-
ing factor 1 was provided by L. Li (SIBCB, Shanghai, China), HA-p50 and 
mp40-luc were provided by B. Sun (SIBCB, Shanghai, China), myc-cRel 
was provided by B. Huang (Northeast Normal University, Changchun, 
China), and A20 was provided by L. Guo (SIBCB, Shanghai, China).
Yeast two-hybrid screening
A cDNA fragment encoding residues 1–312 of human p65 was inserted in 
frame into the Gal4 DNA-binding domain vector pGBKT7. A human thymus UXT AS AN ESSENTIAL COFACTOR FOR NF-𝗋B • SUN ET AL. 243
cDNA library (CLONTECH Laboratories, Inc.) was screened according to 
protocols recommended by the manufacturer.
Cell culture and transfection
293T and RAW264.7 cells were cultured in DME (Invitrogen) supple-
mented with 10% FBS (Hyclone). PC-3 cells were cultured in RPMI 1640 
medium (Invitrogen) supplemented with 10% FBS, and LNCaP cells were 
cultured in Ham’s F12 medium (Invitrogen) supplemented with 10% FBS. 
All transfections were performed using LipofectAMINE 2000 (Invitrogen) 
according to the manufacturer’s instructions.
Reporter assays
Cells were seeded in 24-well plates and transfected with 40 pmol siRNA 
combined with reporters and other constructs as indicated. The total 
amount of DNA was kept constant by supplementing with pcDNA3. pRL-
SV40 (Promega) was cotransfected to normalize transfection efﬁ  ciency. 48 h 
after transfection, cells were treated with the indicated reagents or left un-
treated. Luciferase activity was analyzed with the Dual Luciferase   Reporter 
Assay System (Promega).
In vitro translation
UXT and p65 were in vitro translated and labeled with [
35S]methionine us-
ing the TNT Quick Coupled Transcription/Translation System (Promega) 
according to the manufacturer’s instructions.
Real-time RT-PCR
Total RNA was isolated with TRIzol (Invitrogen) according to the manufac-
turer’s instructions. Reverse transcription of puriﬁ  ed RNA was performed 
using oligonucleotide dT primer. The quantiﬁ  cation of gene transcripts was 
performed by real-time PCR using SYBR green I dye (Invitrogen). Expression 
values were normalized with control β-actin. The primers used are listed as 
follows: IL-8, sense (A  G  G  T  G  C  A  G  T  T  T  T  G  C  C  A  A  G  G  A  ) and antisense (T  T  T  C  T-
G  T  G  T  T  G  G  C  G  C  A  G  T  G  T  ); IκBα, sense (C  T  G  A  G  C  T  C  C  G  A  G  A  C  T  T  T  C  G  A  G  G  ) 
and antisense (C  A  C  G  T  G  T  G  G  C  C  A  T  T  G  T  A  G  T  T  G  G  ); A20, sense (G  C  G  T  T-
C  A  G  G  A  C  A  C  A  G  A  C  T  T  G  ) and antisense (G  C  A  A  A  G  C  C  C  C  G  T  T  T  C  A  A  C  A  A  ); 
UXT, sense (T  T  T  G  G  G  C  T  G  T  A  A  C  T  T  C  T  T  C  G  T  ) and antisense (A  T  A  T  T  C  A  T  G-
G  A  G  T  C  C  T  T  G  G  T  G  ); CARM1, sense (T  G  C  C  G  A  C  C  G  C  C  T  A  T  G  A  C  T  ) and 
antisense (C  C  C  G  T  G  T  T  G  G  C  T  A  A  A  G  G  A  A  ); β-actin, sense (A  A  A  G  A  C  C  T  G  T-
A  C  G  C  C  A  A  C  A  C  ) and antisense (G  T  C  A  T  A  C  T  C  C  T  G  C  T  T  G  C  T  G  A  T  ).
EMSA
EMSAs were performed as described previously (Yang et al., 2006). The 
probes used are as follows: wild-type κB probe (A  G  T  T  G  A  G  G  G  G  A  C  T  T  T  C-
C  C  A  G  G  C  ), mutant κB probe (A  G  T  T  G  A  G  G  C  G  A  C  T  T  T  C  C  C  A  G  G  C  ), and 
sp1 probe (A  T  T  C  G  A  T  C  G  G  G  G  C  G  G  G  G  C  G  A  G  C  ).
ChIP assay
The ChIP assay kit (Upstate Biotechnology) was used according to the man-
ufacturer’s instructions with some variations. Formaldehyde cross-linking 
was performed at room temperature for 10 min before glycine was added 
to a ﬁ  nal concentration of 125 mM for 5 min. The cells were rapidly col-
lected and lysed in SDS lysis buffer. Suspended chromatin was sheared by 
sonication to a mean size of 200–1,000 bp, centrifuged to pellet debris, 
and diluted 10 times with dilution buffer. Extracts were precleared for 2 h 
with salmon sperm DNA and BSA-saturated protein A/G beads. Immuno-
precipitations were performed at 4°C overnight using antibodies as indi-
cated with IgG as a negative control. Immune complexes were collected 
and washed sequentially with Tris-SDS-EDTA buffer I, II, and III followed by 
two washes with Tris-EDTA buffer. Immune complexes were then extracted 
with elution buffer and DNA: protein complexes were disrupted by heating 
at 65°C overnight. After proteinase K digestion for 1 h, DNA was extracted 
with phenolchloroform and precipitated in ethanol. About one twentieth of 
precipitated DNA was used as template in each PCR reaction. The fol-
lowing promoter-speciﬁ  c primers were used: human A20, sense (C  A  G  C  C-
C  G  A  C  C  C  A  G  A  G  A  G  T  C  A  C  ) and antisense (C  G  G  G  C  T  C  C  A  A  G  C  T  C  G  C  T  T  ); 
human GAPDH, sense (A  G  C  T  C  A  G  G  C  C  T  C  A  A  G  A  C  C  T  T  ) and antisense 
(A  A  G  A  A  G  A  T  G  C  G  G  C  T  G  A  C  T  G  T  ); and human IκBα, sense (T  A  G  T  G  G  C  T  C-
A  T  C  G  C  A  G  G  G  A  G  ) and antisense (T  C  A  G  G  C  T  C  G  G  G  G  A  A  T  T  T  C  C  ).
Immunoﬂ  uorescence and microscopy
Cells grown on coverslips were ﬁ  xed with 4% PFA, permeabilized in 0.1% 
Triton X-100, blocked by 1% BSA, and stained with the indicated primary 
antibodies followed by FITC-conjugated anti–mouse IgG (Jackson Immuno-
Research Laboratories). Nuclei were counterstained with DAPI (Sigma-
Aldrich). Slides were mounted by Aqua-Poly/Mount (Polysciences). 
Images were captured at room temperature using a confocal microscope 
(TCS SP2 ACBS; Leica) with a 63× NA 1.4 oil objective (Leica) except 
those in Fig. 2 C, which were captured using a camera (DP70; Olympus) 
on a microscope (BX51; Olympus) with a 10× NA 0.3 objective. The 
  acquiring software was TCS (Leica) or DPcontrol (Olympus).
Apoptosis assay
293T cells were transfected with the indicated siRNA. 48 h after transfec-
tion, cells were treated with 50 ng/ml TNF-α and 5 μg/ml CHX or left un-
treated for 18 h. Floating and adherent cells were collected and analyzed 
using the annexin V–phycoerythrin Apoptosis Detection kit I (BD Bio-
sciences) and In Situ Cell Death Detection kit (TUNEL; Roche) according to 
the manufacturer’s instructions. The ﬂ  ow cytometer used was a FACSCalibur 
(BD Biosciences).
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